Brainstorm-Cell Therapeutics
7 clinical trials · Sponsor
◉ Watch Brainstorm-Cell Therapeutics
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) (NCT06973629) | Brainstorm-Cell Therapeutics | 2025-06-30 |
| Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS (NCT03799718) | Brainstorm-Cell Therapeutics | 2019-03-13 |
Track Brainstorm-Cell Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.